This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Experts weigh withdrawal of three asthma drugs
A panel of 14 lung experts meets to decide if Advair Serevent and Foradil should stay on the market, be relabeled, or be removed due to safety concerns. FDA notes safety signals of severe asthma exacerbations. Advair and Serevent carry warnings from a prior study with 13 deaths among 13,176 users.
MENTIONED IN THIS ARTICLE
Advair
Serevent
GlaxoSmithKline
Novartis
United States
Schering Plough
Advait
Food and Drug Administration
David Graham
Drug Agency
FDA
Erwin W. Gelfand
National Jewish Medical and Research Center